ScreenerHero
TECNTecan Group AG
SWX · CH · Healthcare · Medical Instruments & Supplies · tecan.com
191.10CHF-2.99%Mkt Cap: 2.69B $P/E: —

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Busi…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Société anonyme
$81.53BUSDP/E 30.5
BOX
Becton, Dickinson and Company
$49.98BUSDP/E 34.1
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon Inc.
$32.44BUSDP/E 55.0
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech S.A.
$20.46BUSDP/E 64.5
SRT3
Sartorius Aktiengesellschaft
$18.52BUSDP/E 86.9
STMN
Straumann Holding AG
$16.89BUSDP/E 40.2
SRT
Sartorius Aktiengesellschaft
$14.73BUSDP/E 69.1
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0

Key Statistics

Company
Market Cap2.69B $
Enterprise Value2.76B $
Revenue (TTM)993.54M $
Gross Profit354.76M $
Net Income (TTM)-126.29M $
Revenue/Share79.45 USD
Last Price191.10 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)25.06
PEG1.71
EV/EBITDA33.04
EV/Revenue2.78
P/S2.75
P/B2.11
EPS (TTM)-9.16
EPS (Forward)7.74
52W Range
110.6088% of range202.00
52W High202.00 CHF
52W Low110.60 CHF
Profitability
Gross Margin35.22%
Oper. Margin4.16%
EBITDA Margin8.40%
Profit Margin-12.54%
ROE-9.61%
ROA-6.52%
Growth
Revenue Growth-2.70%
Earnings Growth-29.80%
Cash Flow & Leverage
Operating CF157.47M $
CapEx (TTM)40.29M $
FCF Margin5.53%
FCF Yield2.04%
Net Debt-11.60M $
Net Debt/EBITDA-0.14
Balance Sheet
Debt/Equity0.19
Current Ratio2.32
Quick Ratio1.50
Book Value/Sh91.87 CHF
Cash/Share18.22 CHF
Dividends
Fwd Div Rate3.000 CHF
Trail. Div Rate3.000 CHF
Div. Yield1.52%
5Y Avg Yield1.18%
Payout Ratio60.61%
Ex-Div DateApr 17, 2026
Pay DateApr 16, 2025
Analyst Consensus
Rating2.1 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)182.60 CHF
Upside (mean)-4.4%
Target Range160.00 CHF – 222.00 CHF
CHF160.00-4.4% to meanCHF222.00
# Analysts8
Ownership
Shares Out.12.32M
Float12.27M
Insiders0.43%
Institutions68.10%
Technical
SMA 50175.93 (+8.6%)
SMA 200145.32 (+31.5%)
Beta1.08
S&P 52W Chg18.16%
Avg Vol (30d)52.77K
Avg Vol (10d)72.61K
Technical Indicators
RSI (14)59.7
MACD4.8592
MACD Signal5.4548
MACD Hist.-0.5956
BB Upper202.24 CHF
BB Middle188.60 CHF
BB Lower174.96 CHF
BB Width14.47%
ATR (14)7.637 CHF
Vol Ratio (20d)0.89x